1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Neurovascular Thrombectomy Device Revenue
1.4 Market Analysis by Type
1.4.1 Global Neurovascular Thrombectomy Device Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Mechanical/Fragmentation Thrombectomy Devices
1.4.3 Stent Retrievers
1.4.4 Basket/Brush Retrievers
1.4.5 Coil Retrievers
1.4.6 Aspiration Thrombectomy Devices
1.4.7 Rheolytic/Hydrodynamic Thrombectomy Devices
1.4.8 Ultrasonic Thrombectomy Devices
1.5 Market by Application
1.5.1 Global Neurovascular Thrombectomy Device Market Share by Application: 2021-2026
1.5.2 Hospitals and Surgical Centers
1.5.3 Ambulatory Surgical Centers
1.5.4 Research Laboratories & Academic Institutes
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered
1.8 Overview of Global Neurovascular Thrombectomy Device Market
1.8.1 Global Neurovascular Thrombectomy Device Market Status and Outlook (2015-2026)
1.8.2 North America
1.8.3 East Asia
1.8.4 Europe
1.8.5 South Asia
1.8.6 Southeast Asia
1.8.7 Middle East
1.8.8 Africa
1.8.9 Oceania
1.8.10 South America
1.8.11 Rest of the World
2 Market Competition by Manufacturers
2.1 Global Neurovascular Thrombectomy Device Production Capacity Market Share by Manufacturers (2015-2020)
2.2 Global Neurovascular Thrombectomy Device Revenue Market Share by Manufacturers (2015-2020)
2.3 Global Neurovascular Thrombectomy Device Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Neurovascular Thrombectomy Device Production Sites, Area Served, Product Type
3 Sales by Region
3.1 Global Neurovascular Thrombectomy Device Sales Volume Market Share by Region (2015-2020)
3.2 Global Neurovascular Thrombectomy Device Sales Revenue Market Share by Region (2015-2020)
3.3 North America Neurovascular Thrombectomy Device Sales Volume
3.3.1 North America Neurovascular Thrombectomy Device Sales Volume Growth Rate (2015-2020)
3.3.2 North America Neurovascular Thrombectomy Device Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.4 East Asia Neurovascular Thrombectomy Device Sales Volume
3.4.1 East Asia Neurovascular Thrombectomy Device Sales Volume Growth Rate (2015-2020)
3.4.2 East Asia Neurovascular Thrombectomy Device Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.5 Europe Neurovascular Thrombectomy Device Sales Volume (2015-2020)
3.5.1 Europe Neurovascular Thrombectomy Device Sales Volume Growth Rate (2015-2020)
3.5.2 Europe Neurovascular Thrombectomy Device Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.6 South Asia Neurovascular Thrombectomy Device Sales Volume (2015-2020)
3.6.1 South Asia Neurovascular Thrombectomy Device Sales Volume Growth Rate (2015-2020)
3.6.2 South Asia Neurovascular Thrombectomy Device Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.7 Southeast Asia Neurovascular Thrombectomy Device Sales Volume (2015-2020)
3.7.1 Southeast Asia Neurovascular Thrombectomy Device Sales Volume Growth Rate (2015-2020)
3.7.2 Southeast Asia Neurovascular Thrombectomy Device Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.8 Middle East Neurovascular Thrombectomy Device Sales Volume (2015-2020)
3.8.1 Middle East Neurovascular Thrombectomy Device Sales Volume Growth Rate (2015-2020)
3.8.2 Middle East Neurovascular Thrombectomy Device Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.9 Africa Neurovascular Thrombectomy Device Sales Volume (2015-2020)
3.9.1 Africa Neurovascular Thrombectomy Device Sales Volume Growth Rate (2015-2020)
3.9.2 Africa Neurovascular Thrombectomy Device Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.10 Oceania Neurovascular Thrombectomy Device Sales Volume (2015-2020)
3.10.1 Oceania Neurovascular Thrombectomy Device Sales Volume Growth Rate (2015-2020)
3.10.2 Oceania Neurovascular Thrombectomy Device Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.11 South America Neurovascular Thrombectomy Device Sales Volume (2015-2020)
3.11.1 South America Neurovascular Thrombectomy Device Sales Volume Growth Rate (2015-2020)
3.11.2 South America Neurovascular Thrombectomy Device Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.12 Rest of the World Neurovascular Thrombectomy Device Sales Volume (2015-2020)
3.12.1 Rest of the World Neurovascular Thrombectomy Device Sales Volume Growth Rate (2015-2020)
3.12.2 Rest of the World Neurovascular Thrombectomy Device Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
4 North America
4.1 North America Neurovascular Thrombectomy Device Consumption by Countries
4.2 United States
4.3 Canada
4.4 Mexico
5 East Asia
5.1 East Asia Neurovascular Thrombectomy Device Consumption by Countries
5.2 China
5.3 Japan
5.4 South Korea
6 Europe
6.1 Europe Neurovascular Thrombectomy Device Consumption by Countries
6.2 Germany
6.3 United Kingdom
6.4 France
6.5 Italy
6.6 Russia
6.7 Spain
6.8 Netherlands
6.9 Switzerland
6.10 Poland
7 South Asia
7.1 South Asia Neurovascular Thrombectomy Device Consumption by Countries
7.2 India
7.3 Pakistan
7.4 Bangladesh
8 Southeast Asia
8.1 Southeast Asia Neurovascular Thrombectomy Device Consumption by Countries
8.2 Indonesia
8.3 Thailand
8.4 Singapore
8.5 Malaysia
8.6 Philippines
8.7 Vietnam
8.8 Myanmar
9 Middle East
9.1 Middle East Neurovascular Thrombectomy Device Consumption by Countries
9.2 Turkey
9.3 Saudi Arabia
9.4 Iran
9.5 United Arab Emirates
9.6 Israel
9.7 Iraq
9.8 Qatar
9.9 Kuwait
9.10 Oman
10 Africa
10.1 Africa Neurovascular Thrombectomy Device Consumption by Countries
10.2 Nigeria
10.3 South Africa
10.4 Egypt
10.5 Algeria
10.6 Morocco
11 Oceania
11.1 Oceania Neurovascular Thrombectomy Device Consumption by Countries
11.2 Australia
11.3 New Zealand
12 South America
12.1 South America Neurovascular Thrombectomy Device Consumption by Countries
12.2 Brazil
12.3 Argentina
12.4 Columbia
12.5 Chile
12.6 Venezuela
12.7 Peru
12.8 Puerto Rico
12.9 Ecuador
13 Rest of the World
13.1 Rest of the World Neurovascular Thrombectomy Device Consumption by Countries
13.2 Kazakhstan
14 Sales Volume, Sales Revenue, Sales Price Trend by Type
14.1 Global Neurovascular Thrombectomy Device Sales Volume Market Share by Type (2015-2020)
14.2 Global Neurovascular Thrombectomy Device Sales Revenue Market Share by Type (2015-2020)
14.3 Global Neurovascular Thrombectomy Device Sales Price by Type (2015-2020)
15 Consumption Analysis by Application
15.1 Global Neurovascular Thrombectomy Device Consumption Volume by Application (2015-2020)
15.2 Global Neurovascular Thrombectomy Device Consumption Value by Application (2015-2020)
16 Company Profiles and Key Figures in Neurovascular Thrombectomy Device Business
16.1 Stryker Corporation (U.S.)
16.1.1 Stryker Corporation (U.S.) Company Profile
16.1.2 Stryker Corporation (U.S.) Neurovascular Thrombectomy Device Product Specification
16.1.3 Stryker Corporation (U.S.) Neurovascular Thrombectomy Device Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.2 Edwards Lifesciences Corporation (U.S.)
16.2.1 Edwards Lifesciences Corporation (U.S.) Company Profile
16.2.2 Edwards Lifesciences Corporation (U.S.) Neurovascular Thrombectomy Device Product Specification
16.2.3 Edwards Lifesciences Corporation (U.S.) Neurovascular Thrombectomy Device Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.3 Johnson & Johnson (U.S.)
16.3.1 Johnson & Johnson (U.S.) Company Profile
16.3.2 Johnson & Johnson (U.S.) Neurovascular Thrombectomy Device Product Specification
16.3.3 Johnson & Johnson (U.S.) Neurovascular Thrombectomy Device Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.4 Medtronic plc (Ireland)
16.4.1 Medtronic plc (Ireland) Company Profile
16.4.2 Medtronic plc (Ireland) Neurovascular Thrombectomy Device Product Specification
16.4.3 Medtronic plc (Ireland) Neurovascular Thrombectomy Device Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.5 Spectranetics Corporation (U.S.)
16.5.1 Spectranetics Corporation (U.S.) Company Profile
16.5.2 Spectranetics Corporation (U.S.) Neurovascular Thrombectomy Device Product Specification
16.5.3 Spectranetics Corporation (U.S.) Neurovascular Thrombectomy Device Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.6 Boston Scientific Corporation (U.S.)
16.6.1 Boston Scientific Corporation (U.S.) Company Profile
16.6.2 Boston Scientific Corporation (U.S.) Neurovascular Thrombectomy Device Product Specification
16.6.3 Boston Scientific Corporation (U.S.) Neurovascular Thrombectomy Device Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.7 Teleflex Incorporated (U.S.)
16.7.1 Teleflex Incorporated (U.S.) Company Profile
16.7.2 Teleflex Incorporated (U.S.) Neurovascular Thrombectomy Device Product Specification
16.7.3 Teleflex Incorporated (U.S.) Neurovascular Thrombectomy Device Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.8 Penumbra, Inc. (U.S.)
16.8.1 Penumbra, Inc. (U.S.) Company Profile
16.8.2 Penumbra, Inc. (U.S.) Neurovascular Thrombectomy Device Product Specification
16.8.3 Penumbra, Inc. (U.S.) Neurovascular Thrombectomy Device Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.9 Terumo Corporation (Japan)
16.9.1 Terumo Corporation (Japan) Company Profile
16.9.2 Terumo Corporation (Japan) Neurovascular Thrombectomy Device Product Specification
16.9.3 Terumo Corporation (Japan) Neurovascular Thrombectomy Device Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.10 Argon Medical Devices, Inc. (U.S.)
16.10.1 Argon Medical Devices, Inc. (U.S.) Company Profile
16.10.2 Argon Medical Devices, Inc. (U.S.) Neurovascular Thrombectomy Device Product Specification
16.10.3 Argon Medical Devices, Inc. (U.S.) Neurovascular Thrombectomy Device Production Capacity, Revenue, Price and Gross Margin (2015-2020)
17 Neurovascular Thrombectomy Device Manufacturing Cost Analysis
17.1 Neurovascular Thrombectomy Device Key Raw Materials Analysis
17.1.1 Key Raw Materials
17.2 Proportion of Manufacturing Cost Structure
17.3 Manufacturing Process Analysis of Neurovascular Thrombectomy Device
17.4 Neurovascular Thrombectomy Device Industrial Chain Analysis
18 Marketing Channel, Distributors and Customers
18.1 Marketing Channel
18.2 Neurovascular Thrombectomy Device Distributors List
18.3 Neurovascular Thrombectomy Device Customers
19 Market Dynamics
19.1 Market Trends
19.2 Opportunities and Drivers
19.3 Challenges
19.4 Porter's Five Forces Analysis
20 Production and Supply Forecast
20.1 Global Forecasted Production of Neurovascular Thrombectomy Device (2021-2026)
20.2 Global Forecasted Revenue of Neurovascular Thrombectomy Device (2021-2026)
20.3 Global Forecasted Price of Neurovascular Thrombectomy Device (2015-2026)
20.4 Global Forecasted Production of Neurovascular Thrombectomy Device by Region (2021-2026)
20.4.1 North America Neurovascular Thrombectomy Device Production, Revenue Forecast (2021-2026)
20.4.2 East Asia Neurovascular Thrombectomy Device Production, Revenue Forecast (2021-2026)
20.4.3 Europe Neurovascular Thrombectomy Device Production, Revenue Forecast (2021-2026)
20.4.4 South Asia Neurovascular Thrombectomy Device Production, Revenue Forecast (2021-2026)
20.4.5 Southeast Asia Neurovascular Thrombectomy Device Production, Revenue Forecast (2021-2026)
20.4.6 Middle East Neurovascular Thrombectomy Device Production, Revenue Forecast (2021-2026)
20.4.7 Africa Neurovascular Thrombectomy Device Production, Revenue Forecast (2021-2026)
20.4.8 Oceania Neurovascular Thrombectomy Device Production, Revenue Forecast (2021-2026)
20.4.9 South America Neurovascular Thrombectomy Device Production, Revenue Forecast (2021-2026)
20.4.10 Rest of the World Neurovascular Thrombectomy Device Production, Revenue Forecast (2021-2026)
20.5 Forecast by Type and by Application (2021-2026)
20.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2021-2026)
20.5.2 Global Forecasted Consumption of Neurovascular Thrombectomy Device by Application (2021-2026)
21 Consumption and Demand Forecast
21.1 North America Forecasted Consumption of Neurovascular Thrombectomy Device by Country
21.2 East Asia Market Forecasted Consumption of Neurovascular Thrombectomy Device by Country
21.3 Europe Market Forecasted Consumption of Neurovascular Thrombectomy Device by Countriy
21.4 South Asia Forecasted Consumption of Neurovascular Thrombectomy Device by Country
21.5 Southeast Asia Forecasted Consumption of Neurovascular Thrombectomy Device by Country
21.6 Middle East Forecasted Consumption of Neurovascular Thrombectomy Device by Country
21.7 Africa Forecasted Consumption of Neurovascular Thrombectomy Device by Country
21.8 Oceania Forecasted Consumption of Neurovascular Thrombectomy Device by Country
21.9 South America Forecasted Consumption of Neurovascular Thrombectomy Device by Country
21.10 Rest of the world Forecasted Consumption of Neurovascular Thrombectomy Device by Country
22 Research Findings and Conclusion
23 Methodology and Data Source
23.1 Methodology/Research Approach
23.1.1 Research Programs/Design
23.1.2 Market Size Estimation
23.1.3 Market Breakdown and Data Triangulation
23.2 Data Source
23.2.1 Secondary Sources
23.2.2 Primary Sources
23.3 Disclaimer